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Abstract
A  58-year-old  female  without  cardiovascular  risk  factors,  was  going  to  be  operated  to  repair
the  rotator  cuff.  Induction  and  interscalene  brachial  plexus  block  were  uneventful,  but  after
her  placement  for  surgery  the  patient  started  with  severe  bronchospasm,  hypotension,  cuta-
neous  allergic  reaction  and  ST  elevation  on  the  electrocardiogram.  An  anaphylactic  shock  was
suspected  and  treated  but  until  the  perfusion  of  nitroglycerina  was  started  no  electrocardio-
graphic  changes  resolved.  After  necessary  diagnostic  test  the  ﬁnal  diagnosis  was  variant  I  of
Kounis  syndrome  due  to  cefazolin  and  rocuronium.  Ephinephrine  is  the  cornerstone  of  treat-
ment  for  anaphylaxis  but  should  we  use  it  if  the  anaphylactic  reaction  is  also  accompanied  by
myocardial  ischemia?  The  answer  is  that  we  should  not  use  it  because  myocardial  ischemia  in
this  syndrome  is  caused  by  vasospasm,  so  it  would  be  more  useful  drugs  such  as  nitroglycerin.
But what  if  we  do  not  know  if  it  is  a  Kounis  syndrome  or  not?  In  this  article  we  report  our
experience  that  maybe  could  help  you  in  a  similar  situation.
©  2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Síndrome  de  Kounis;
Cefazolina;
Rocurônio
Síndrome  de  Kounis  intraoperatória  com  melhoria  das  alterac¸ões  eletrocardiográﬁcas
e  da  situac¸ão  hemodinâmica  após  a  administrac¸ão  de  nitroglicerina
Resumo
Paciente  do  sexo  feminino,  58  anos,  sem  fator  de  risco  cardiovascular,  submetida  a  cirurgia
Este é um artigo Open Access sob a licença de CC BY-NC-NDpara  reparac¸ão  do  manguito  rotador.  A  induc¸ão  do  bloqueio  do  plexo  braquial  interescalênico
foi feita  sem  intercorrência,  mas,  após  seu  posicionamento  para  a  cirurgia,  a  paciente  apre-
sentou  broncoespasmo  grave,  hipotensão,  reac¸ão  alérgica  cutânea  e  elevac¸ão  do  segmento
ST ao  eletrocardiograma.  Houve  suspeita  de  choque  anaﬁlático  que  foi  tratado,  mas  até
que  a  perfusão  de  nitroglicerina  fosse  iniciada  não  houve  resoluc¸ão  das  alterac¸ões  eletro-
cardiográﬁcas.  Após  teste  diagnóstico  necessário,  o  diagnóstico  ﬁnal  foi  de  variante  tipo  I
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da  síndrome  de  Kounis  por  causa  de  cefazolina  e  rocurônio.  Epinefrina  é  a  base  sólida  do  trata-
mento  para  anaﬁlaxia,  mas  devemos  usá-la  se  a  reac¸ão  anaﬁlática  também  for  acompanhada
de isquemia  miocárdica?  A  resposta  é  que  não  devemos  usá-la,  porque  a  isquemia  miocárdica
nessa  síndrome  é  causada  por  vasoespasmo;  portanto,  drogas  como  a  nitroglicerina  seriam  mais
úteis.  Porém,  e  quando  não  sabemos  se  é  ou  não  uma  síndrome  de  Kounis?  Neste  artigo  relatamos
nossa  experiência  que,  talvez,  possa  ajudar  em  uma  situac¸ão  similar.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos  reservados.
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ounis  syndrome  was  ﬁrst  described  in  1991  by  Nicholas  Kou-
is and  Zavras  in  the  study:  ‘‘Histamine-induced  coronary
rtery spasm:  the  concept  of  allergic  angina’’.1
Kounis  syndrome  is  characterized  by  the  simultaneous
ppearance of  an  allergic  reaction  and  an  acute  coronary
yndrome. It  is  also  known  as  allergic  angina  or  allergic
yocardial infarction.2 Kounis  syndrome  is  classiﬁed  into
wo groups:
Group I:  patients  without  cardiovascular  risk  factors  and
nor  known  coronary  artery  disease.
Group II:  patients  with  cardiovascular  risk  factors  with  or
without  associated  coronary  artery  disease.
Recently  a  Group  III2-4 has  been  proposed  which  would
elong to  patients  with  drug-eluting  stents  that  are  com-
licated by  thrombosis  and  in  which  the  histology  observed
nﬁltrates of  mast  cells  and  eosinophils.
This  unique  syndrome  is  under-diagnosed  because  it
equires an  electrocardiography  recording  during  the
llergic reaction,  normally  prioritizing  the  treatment  of  ana-
hylaxis, and  when  we  ﬁnally  do  the  electrocardiogram  it  is
o longer  altered.  Moreover,  many  of  these  reactions  occur
n the  street  and  when  patients  reach  the  health  center
heir electrocardiograms  are  normal,  because  the  electrical
hanges tend  to  disappear  in  a  brief  period  of  time.
The  question  arises  at  the  moment  of  using  epinephrine.
pinephrine is  the  cornerstone  of  treatment  for  anaphylactic
hock, but  we  should  think  twice  before  using  it  in  Kou-
is syndrome  because  it  could  aggravate  cardiac  ischemia
roduced by  vasospasm.
This doubt  also  occurs  with  other  drugs  like  aspirin,  indi-
ated in  the  treatment  of  acute  coronary  syndrome  but
hich in  turn  may  cause  anaphylactic  reactions,  or  in  the
ase of  nitro-glycerine  that  is  also  used  in  acute  coronary
yndrome, but  could  worsen  the  hypotension  and  tachycar-
ia caused  by  anaphylaxis.5
We  report  a  case  of  intraoperative  Kounis  syndrome  that
as resolved  mainly  due  to  the  administration  of  nitro-
lycerine.
ase report 58-year-old  women  and  65  kg  with  hypercholesterolemia
n dietary  treatment  and  operated  of  ﬁbro  adenoma  breast
nd tonsils.  She  had  no  personal  or  family  history  of  allergy.
m
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nThe patient  was  going  to  be  operated  to  arthroscopically
epair the  rotator  cuff.  In  the  operating  room  she  was  mon-
tored by  pulse  oximetry,  non-invasive  blood  pressure  and
lectrocardiogram. She  was  hemodynamically  stable  with  a
lood pressure  of  190/90  mmHg  and  was  anxious.
As premedication  she  received  2  g  cefazolin,  50  mg  rani-
idine, and  4  mg  of  ondasentron.  In  the  operating  room  she
as administered  midazolam  2  mg,  propofol  10  mg  and  dexa-
ethasone 4  mg.
She was  performed  an  interscalene  brachial  plexus  block
ith ropivacaine  0.5%  20  mL  without  complications.  It  was
roceeded to  induct  fentanyl  300  g;  propofol  100  mg;
tropine 0.5  mg  and  50  mg  rocuronium.  She  was  intubated  by
rotracheal via  and  maintained  with  inhalation  anesthesia
ith sevoﬂurane.  She  was  administered  preemptive  anal-
esia with  paracetamol  1  g  and  dexketoprofen  50  mg  and
laced in  the  lateral  decubitus  position  for  surgery.
Traumatologists  made  cutaneous  incision  use  to  inﬁl-
rate lidocaine  4  mg  with  epinephrine  25  g.  Suddenly
e observed  an  increase  in  heart  rate  of  140  bpm,  fol-
owed by  severe  bronchospasm  with  difﬁculty  in  mechanical
entilation, with  pressures  up  to  40  cmH2O  in  the  air-
ay. Cardiopulmonary  auscultation  was  tachycardia  and
ypoventilation with  decrease  in  vesicular  murmur.  Subse-
uently, end  tidal  carbon  dioxide  descended  to  9  mmHg,
nd oxygen  saturation  to  75%.  Finally  we  observed  the
T elevation  in  leads  II  and  III  on  the  monitor.  Until  that
oment measurement  of  blood  pressure  was  programmed
very 5  min  so,  in  this  instant  marked  120/70  mmHg.
Surgery was  interrupted  immediately,  the  patient  was
laced in  decubitus  supine,  we  started  manual  ventilation
ith FiO2 of  1.  Then  the  measurement  of  blood  pressure
evealed a  hypotension  of  63/39  mmHg,  and  we  stopped
he administration  of  sevoﬂurane  and  started  with  intensive
uid therapy.  When  we  removed  the  cloth  from  the  surgi-
al ﬁeld  we  observed  generalized  skin  rash.  It  was  made  a
welve-lead electrocardiogram  in  which  we  could  see  ST  seg-
ent  elevation  in  the  front  and  bottom  of  the  heart  (Fig.  1).
An  emergent  consultation  to  cardiologist  recommended
mplementing the  hospital  protocol  of  acute  coronary  syn-
rome, with  perfusion  of  nitroglycerine  at  titrated  doses,
epending on  the  patient’s  hemodynamic  situation,  clopid-
grel 300  mg  and  acetylsalicylic  acid  100  mg  by  nasogastric
ube.
Suspecting an  anaphylactic  reaction,  we  administered
ethylprednisolone  80  mg  IV,  dexchlorpheniramine  maleate
 mg  IV  and  ranitidine  50  mg  IV.  At  ﬁrst  we  were  not  sure
hether to  use  adrenaline  or  not,  but  ﬁnally  it  was  decided
ot to  administer  it  given  the  possibility  of  the  patient
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Figure  1  ST  segment  elevation  in  front  and  bottom  of  the  heart.
A
fsuffering  an  acute  coronary  syndrome.  She  needed
ephedrine boluses  of  5,  10  and  20  mg  to  stabilize  blood  pres-
sure and  atropine  1  mg  for  bradycardia.  This  allowed  starting
acute coronary  syndrome  protocol.
Following  our  hospital  allergy  protocol,  blood  and  urine
samples were  extracted.
After waiting  during  the  safety  period  it  was  decided
to revive  the  patient.  She  was  asymptomatic,  the  rash  had
diminished and  the  electrocardiogram  was  normal  (Fig.  2).
She  was  admitted  to  ICU  after  performing  the  following
tests:
- Coronary  angiography:  normal
- General  analysis:  without  alterations,  absence  of
eosinophilia.
-  Chest  X:  rise  of  the  right  hemidiaphragm  (Fig.  3),  probablyrelated  to  interscalene  brachial  plexus  block.  Normalized
in discharge.
-  Electrocardiogram:  unchanged.
- Serial  myocardial  enzymes:  normal. tShe  was  discharged  from  hospital  and  attended  by  the
llergy department  where  the  study  was  continued  with  the
ollowing test:
Levels of  serum  tryptase  66.4  pg/L,  during  anaphylactic
shock,  34.3  pg/L  after  90  min  and  27.5  pg/L  after  6  h  of
reaction.3 Plasma  histamine  >  200  nmol/L  intraoperatively.
Histamine levels  in  urine  2288  nmol/L  in  the  operating
room and  1693  nmol/L  after  1  h.
Allergy  skin  test  to  latex:  negative.
Protocol of  general  anesthetics:  positive  for  rocuronium
and doubtful  for  cisatracurium.  The  rest  of  the  drugs  tested
were  negative.
Skin and  provocation  test  with  lidocaine  and  dexametha-
sone:  negative.
Skin prick  test:  positive  for  cefazolin.The  ﬁnal  diagnosis  was  type  I  Kounis  syndrome  secondary
o rocuronium6 and/or  cefazolin.
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Figure  2  Normal  ele
Figure  3  Rise  of  the  right  hemidiaphragm.
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iscussion
his  is  a  real  case  of  Kounis  syndrome  type  I,  in  which  elec-
rocardiography abnormalities  were  resolved  with  the  help
f nitro-glycerine;  so  how  was  severe  hypotension  improved
y using  nitro-glycerine?  This  could  be  explained  because  in
his syndrome,  heart  failure  is  mainly  produced  by  coronary
asospasm produced  in  turn  by  massive  activation  mast  cell7
f  cardiac  tissue  and  liberation  of  histamine,  prostaglandin,
hromboxane, leukotrienes8 and  platelet  activating  factor.
Other  clinical  manifestations  may  be  tachycardia,
entricular contraction  dysfunction  and  atrioventricular
locks.9
Boluses  of  ephedrine  helped  to  stabilize  blood  pressure
nd heart  rate,  respectively  but  segment  ST  did  not  normal-
ze until  nitroglycerine  infusion  started.
The  great  doubt  that  we  had  was  the  use  of  adrenaline.
n any  clinical  guideline,  adrenaline  is  the  ‘‘gold  standard’’
reatment for  anaphylactic  shock,  but  its  use  in  a  Kounis
yndrome could  have  serious  consequences.
As  we  have  said  previously,  many  of  these  Kounis  syn-
romes are  undetectable  due  to  the  absence  of  monitoring
n the  acute  phase  and  treatment  with  adrenaline  is
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unquestionable  in  anaphylactic  shock  and  cannot  be
delayed. This  can  aggravate  vasospasm  and  cardiac
ischemia. Furthermore,  in  the  case  we  had  monitored  the
patient, the  use  of  adrenaline  would  have  masked  the
diagnosis of  Kounis  syndrome,  because  you  could  not  have
known whether  the  electrocardiography  changes  were  due
to adrenaline  or  Kounis  syndrome.10
Therefore,  if  we  diagnose  a  Kounis  syndrome,  adrenaline
would not  be  indicated,  or  it  would  have  to  be  used  with  cau-
tion given  that  it  could  aggravate  vasospasm  and  myocardial
ischemia, besides  the  possibility  to  produce  lethal  cardiac
arrhythmias.
On the  other  hand,  if  we  are  faced  with  an  anaphylactic
shock that  we  do  not  know  if  it  is  a  Kounis  syndrome  or  not,
what happens  most  of  the  time,  we  would  not  delay  the  use
of adrenaline6 if  we  need  it,  as  long  as  we  make  a  1:1000
dilution in  the  case  of  intramuscular  route  or  1:10,000  to
1:100,000 if  intravenous  route  is  used.10
To  sum  up,  we  agree  with  using  epinephrine  to  treat  ana-
phylactic shock,  what  we  offer  is  an  alternative  in  case  of
failure to  improve  patient  homodynamic  after  its  admin-
istration: ‘‘the  use  of  nitroclycerine  carefully,  as  long  as
patient’s hemodynamic  status  permits  it,  might  help  if  the
cause of  this  situation  was  a  vasospasm  by  a  possible  Kounis
syndrome’’.
To end,  with  the  clinical  manifestations  and  alterations
in the  results  of  diagnostic  tests  described,  we  should  bear
in mind  in  differential  diagnosis  other  ischemic  heart  dis-
eases like  myocardial  infarction,  stable  and  unstable  angina,
Prinzmetal Angina  and,  of  course  Tako-Tsubo  syndrome.  The
skin reaction  and  elevated  serum  tryptase  levels  will  give  us
the clue  to  diagnose  Kounis  syndrome.
Conclusions
If  we  diagnose  an  anaphylactic  shock,  ﬁrst  treat  it,  and  if  it  is
possible do  an  electrocardiogram  and  extraction  of  samples
for making  the  diagnosis  of  Kounis  syndrome.
If  a  monitored  patient  presents  during  an  anaphylactic
shock electrocardiography  changes  of  acute  coronary  syn-
drome, a  probable  cause  could  be  a  Kounis  syndrome  and  we
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ill  have  to  value  the  use  of  nitroglycerine,  if  the  patient’s
emodynamic situation  permits  it.
If  we  face  an  anaphylactic  shock  that  we  are  not  sure  if  it
s a  Kounis  syndrome,  the  use  of  adrenaline  is  unquestioned,
ut if  we  dilute  it  (1:1000  intramuscularly  or  1:10,000  to
:100,000 intravenously),  we  will  minimize  the  chances  of
ggravating vasospasm,  ischemia  and  arrhythmias  that  may
ause  this  syndrome.
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